A new drug, designed to suppress an overactive immune system and help prevent asthma and food allergies, is being developed by Nobel Prize-winning scientist Barry Marshall.
Professor Marshall, from The University of Western Australia, is developing an oral treatment called ‘Immbalance’, which is designed to restore balance to the immune system and desensitize allergic responses.
Professor Marshall said the drug would harness the immune properties of common bacterium Helicobacter pylori, which naturally resides in the human stomach and move the allergic response down into the normal range.
He believes the drug will likely be a powder that can be consumed by adding it to food and drinks.
It is ready to be manufactured for safety testing on animals and then, when approved, in humans.
It is hoped clinical trials in children will begin in three years.